| CODE | PHR5614 | ||||||||||||
| TITLE | Drug Information and Statistics | ||||||||||||
| UM LEVEL | 05 - Postgraduate Modular Diploma or Degree Course | ||||||||||||
| MQF LEVEL | 7 | ||||||||||||
| ECTS CREDITS | 8 | ||||||||||||
| DEPARTMENT | Pharmacy | ||||||||||||
| DESCRIPTION | The unit presents an overview of drug information sources that are used in healthcare. Critical evaluation of literature in a systematic approach is described. The clinical application of statistical tools is put forward. The concepts of ensuring patient safety and legal and ethical implications when responding to drug information requests are explored. Aspects required in the use of evidence-based medical literature, in the retrieval and analysis of information and literature evaluation for formulary development and disease state management policies are discussed. Pharmacovigilance and drug use monitoring processes are described. - Drug information activities - Interpretation of evidence-based medical literature - Formulary and medication use policies - Health Technology assessments - Pharmacovigilance and Adverse Drug Reactions reporting systems - Clinical trials and Investigational Medicinal Products in clinical settings - Drug use monitoring services Students will be asked to propose models for drug information, pharmacovigilance and clinical trials appraisal as assignments. Study-unit Aims: - To present use of literature when handling drug information requests; - To critically evaluate studies and clinical trials design and reports; - To identify application of different statistical tests. Learning Outcomes: 1. Knowledge & Understanding: By the end of the study-unit the student will be able to: - Recognize and differentiate different statistical tools used in healthcare research; - Describe techniques in researching, interpreting and evaluating drug information sources. 2. Skills: By the end of the study-unit the student will be able to: - Evaluate drug information literature; - Provide drug and health related information which is targeted to specific needs of healthcare professionals and consumers; - Design, develop and evaluate educational information targeted at different levels of audience; - Assess legal and ethical considerations during drug information service provision; - Develop and manage drug information services in different care settings; - Develop comparative efficacy reports and health technology assessments; - Prepare reviews and medication use evaluations. Main Text/s and any supplementary readings: - Dawson B, Trapp RG. Basic and clinical biostatistics. 4th edition. ACCP. 2004 - DiCenzo R. Clinical pharmacist's guide to biostatistics and literature evaluation. ACCP. 2011 - Gehlbach SH. Interpreting the medical literature. 5th edition. ACCP. 2002 - Guyatt G, Rennie D, Meade MO, Cook DJ. Users' guide to the medical literature: a manual for evidence-based clinical practice. 2nd edition. ACCP. 2008 - Malone P, Kier K, Stanovich J. Drug information: A guide for pharmacists. McGraw-Hill. 2010. |
||||||||||||
| STUDY-UNIT TYPE | Independent Online Learning and Tutorials | ||||||||||||
| METHOD OF ASSESSMENT |
|
||||||||||||
| LECTURER/S | Lilian M. Azzopardi Jennifer Hanh-Tran Pham Alan Lau Maria Theresa Christina Mactal Haaf Maresca Attard Pizzuto |
||||||||||||
|
The University makes every effort to ensure that the published Courses Plans, Programmes of Study and Study-Unit information are complete and up-to-date at the time of publication. The University reserves the right to make changes in case errors are detected after publication.
The availability of optional units may be subject to timetabling constraints. Units not attracting a sufficient number of registrations may be withdrawn without notice. It should be noted that all the information in the description above applies to study-units available during the academic year 2023/4. It may be subject to change in subsequent years. |
|||||||||||||